Home
HEALTH CARE
Allergy and hay fever
Antineoplastic and immunomodulating agents
Circulatory system
Colds and flu
Dermatology
Digestive system
Eyes
For diabetics
Homeopathy
Musculoskeletal system
Non-sex hormones
Nutrikosmetics
Pain
Preparations for the treatment of infections
Sex and contraception
The immune system
The nervous system
Urogenital tract
Vitamins and minerals
HEALTHY LIFESTYLE
For athletes
Healthy food
Slimming
HYGIENE
Disinfection
Ear hygiene
Hot and cold compresses
Intimate hygiene
Laundry products
Oral hygiene
Slices and sticks
Urinary incontinence
COSMETICS
Cosmetic articles
For eyelashes and eyebrows
For face
For hair
For hands and nails
For the body
Soap
Sunbathing
To the feet
To the mouth
FOR HIM
Cosmetics for men
Health
PREGNANCY AND MOTHERHOOD
Accessories
Cosmetics for pregnant women
Health in pregnancy
Supporting fertility
CHILD
Baby nutrition
Child health
Cosmetics for children
Hygiene items for children
Oral hygiene (for children)
Scrolling
HEALTH CARE
Lenzetto, spray transdermal solution 1.53 mg/dose, 8.1ml 56 doses — Made in Romania — Free Delivery
Lenzetto, spray transdermal solution 1.53 mg/dose, 8.1ml 56 doses — Made in Romania — Free Delivery
Brand:
GEDEON RICHTER
Product Code:
Lenzetto
Availability:
2 - 3 Days
$40.36
Add to Cart
Description
Product description
Lenzetto transdermal spray is used for hormone replacement therapy (HRT) in the presence of symptoms of estrogen deficiency in postmenopausal women (in women with no menstrual bleeding for at least 6 months or women with surgical menopause with a preserved or removed uterus).
Compound
Active ingredient: estradiol;
1 spray dose (90 µl) contains estradiol 1.53 mg (as estradiol hemihydrate 1.58 mg);
Excipients: octisalate (2-ethylhexyl salicylate), ethanol 96%.
Contraindications
Diagnosed or suspected breast cancer or a history of breast cancer.
An established or suspected estrogen-dependent malignant tumor or a history of this disease (including endometrial cancer);
Vaginal bleeding of unknown etiology;
Untreated endometrial hyperplasia;
Venous thromboembolic diseases in history or at present (deep vein thrombosis, pulmonary embolism);
Diagnosed with thrombophilic disorders (eg, deficiency of protein C, protein S, or antithrombin);
Arterial thromboembolic diseases in history or at present (including angina pectoris, myocardial infarction);
Acute liver disease or a history of liver disease if liver function tests have not returned to normal;
Porfiria;
Hypersensitivity to the active substance or to any of the excipients. Method of application.
Mode of application
The bottle contains 56 doses of the preparation. 1 spray dose is 90 µl. The number of applied sprays is recommended to be noted in the table on the carton.
The vial should be discarded after 56 doses of the preparation, even if the solution remains in it.
Daily dose - 1 application of a fixed dose of spray on dry and healthy skin of the inner surface of the arm between the elbow and wrist. If this is not possible, the spray should be applied to the inner thigh. Do not apply Lenzetto® to the skin of the mammary glands or any area near the mammary glands.
If the intended daily dose is two or three fixed doses, they should be applied to adjacent areas of the skin of the inner surface of the forearm (one after the other, without overlapping them) with an area of about 20 cm 2. Wait about 2 minutes for the solution to dry completely.
Application features
pregnant
Not shown for use.
Children
Not shown for use.
Overdose
After taking high doses of preparations containing estrogens, no pronounced effects were recorded. Women with estrogen overdose may experience nausea and vomiting, breast tenderness, dizziness, abdominal pain, drowsiness/fatigue, and withdrawal bleeding. Treatment of overdose consists in the abolition of the preparation Lenzetto® and the appointment of appropriate symptomatic therapy.
Side effects
From the nervous system: headache.
From the gastrointestinal tract: abdominal pain, nausea.
From the skin and subcutaneous tissues: rash, itching.
From the genital organs and mammary glands: pain in the mammary glands, swelling of the mammary glands, uterine bleeding / vaginal bleeding, including spotting, metrorrhagia.
Data from laboratory and instrumental studies: weight gain, weight loss.
Interaction
No preparation interaction studies have been conducted with Lenzetto®.
Storage conditions
Store at a temperature not exceeding 25°C. Do not refrigerate or freeze! Keep out of the reach of children.
After the start of use, store at a temperature not exceeding 25 ° C. Do not refrigerate or freeze!
Flammable! Keep out of the reach of open flames and heaters.
Shelf life - 3 years.
0 reviews
There are no reviews for this product.